RAC1high NK cell-based immunotherapy in hepatocellular carcinoma via STAT3-NKG2D axis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

RAC1high NK cell-based immunotherapy in hepatocellular carcinoma via STAT3-NKG2D axis

Published:2024-06 Issue: Volume:592 Page:216909
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Shi Xiaoli,Chen Wenwei,Yin Yefeng^ORCID,Cao Hengsong,Wang Xinyi,Jiang Wangjie,Li Qing,Li Xiangcheng,Yu Yue,Wang Xuehao

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Reference39 articles.

1. Immune checkpoint HLA-E:CD94-NKG2A mediates evasion of circulating tumor cells from NK cell surveillance;Liu;Cancer Cell,2023

2. T cell-derived interleukin-22 drives the expression of CD155 by cancer cells to suppress NK cell function and promote metastasis;Briukhovetska;Immunity,2023

3. A pan-cancer single-cell panorama of human natural killer cells;Tang;Cell,2023

4. Chimeric antigen receptor engineered natural killer cells for cancer therapy;Zhang;Exp. Hematol. Oncol.,2023

5. Chimeric antigen receptor-engineered NK cells: new weapons of cancer immunotherapy with great potential;Wang;Exp. Hematol. Oncol.,2022

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RAC1 serves as a prognostic factor and correlated with immune infiltration in liver hepatocellular carcinoma;Journal of Cancer Research and Clinical Oncology;2024-09-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP